The pattern we seen at CES final 12 months continues: startups really Interested by your physique fluids. Vivo isn’t any exception. The corporate already presents a variety of house exams, and has launched a brand new check that may detect urinary tract infections (UTIs).
Vivoo’s At-Residence UTI check simplifies the method of diagnosing urinary tract infections, which have an effect on a staggering 150 million individuals globally annually. The corporate harnesses the facility of your telephone’s digital camera to report and analyze coloration readings of check strips. He then supplies recommendation and context for the readings in his free app.
For girls, who account for 60% of UTIs in the USA, Vivoo’s product may show to be a game-changer. Folks usually He thinks They’ve a urinary tract an infection, however they cannot be bothered going to the physician for it. The power to check at house shortens the method, and the app presents free academic content material, supporting their mission to democratize data in healthcare.
![](https://techcrunch.com/wp-content/uploads/2024/01/20170215-DSC00231.jpg)
Vivoo has a rising variety of exams, and claims to have over 200,000 customers worldwide thus far. Picture credit score: TechCrunch/Haj Camps
Vivoo’s journey to rework private well being administration started with the launch of its ‘sensible rest room’ at CES final 12 months, which acquired accolades for its function in early detection of well being circumstances.
With a person base exceeding 200,000 and a rising vary of at-home exams, together with well being indicators comparable to hydration ranges and nutritional vitamins, Vivoo’s partnership with Goal and its world distribution community goals to make private well being administration a actuality for tens of millions all over the world.